Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000663280 | SCV000786517 | likely benign | Cowden syndrome 1 | 2018-05-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000827092 | SCV000968709 | likely benign | not provided | 2018-05-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV001525142 | SCV001735182 | likely benign | Hereditary cancer-predisposing syndrome | 2020-10-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002060803 | SCV002356196 | likely benign | PTEN hamartoma tumor syndrome | 2023-09-01 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001525142 | SCV002528225 | likely benign | Hereditary cancer-predisposing syndrome | 2022-01-13 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV000663280 | SCV004019932 | likely benign | Cowden syndrome 1 | 2023-04-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Department of Pathology and Laboratory Medicine, |
RCV001354121 | SCV001548660 | likely benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The PTEN c.210-12C>T variant was not identified in the literature nor was it identified in the LOVD 3.0 database. The variant was identified in dbSNP (rs766570103) as “with likely benign allele and ClinVar (classified as likely benign by Counsyl). The variant was identified in control databases in 2 of 280,598 chromosomes at a frequency of 0.000007 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Other in 1 of 7150 chromosomes (freq: 0.0001), Latino in 1 of 35,198 chromosomes (freq: 0.00003), while the variant was not observed in the African, Ashkenazi Jewish, East Asian, Finnish, European, and South Asian populations. The c.210-12C>T variant is located at a non-highly conserved nucleotide in the 3' splice region but does not affect the invariant -1 and -2 positions. However, positions -3 and -5 to -12 are part of the splicing consensus sequence and variants involving these positions sometimes affect splicing. 4 out of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |